IP-10 levels are increased in patients with inflammatory states such as autoimmune disease (systemic lupus erythematosus, thyroid disease), acute coronary syndrome, cerebral malaria and allergy[21], [22], [23], [24]. This evidence concerns the gene CXCL10 and systemic lupus erythematosus.